Understanding CMS’s Proposed Rule Regarding Prior Authorization For Drugs
LDI Expert Considers Cost, Quality, and Access Implications
Research & Policy Updates
Congress is Fighting the Wrong Pharmacy Battle
Better Plan Choices Would Lower Drug Costs, Not PBM Breakups, LDI’s Mark Pauly Says
Why Some Family Health Insurance Is Now Much Pricier
LDI Expert Proposes Fixes to Keep Marketplace Plans Within Families' Budgets
Despite Coverage Requirements, Insurers Added Barriers to Access for Drugs
Chart of the Day: Medicare, Medicaid, and Insurers Replaced High Costs With More Hurdles, LDI Expert Finds
Cost Plus Drugs Beats Health Insurance for High-Cost Generics
Chart of the Day: Mark Cuban's Cost Plus Drugs Can Save Employer-Covered Patients Hundreds on Some Generics
Debate Continues Over H.R. 1 Medicaid Changes as Millions Risk Losing Coverage
Will Implementation Create Sweeping Losses or a Return to Balance and Self-Sufficiency?
Insurers Should Incentivize Non-Drug Treatments for Chronic Pain
An LDI Fellow and Chronic Pain Researcher Call on Health Plans To Lower Barriers to Physical Therapy, Acupuncture, and Interdisciplinary Pain Care
Medicaid Reviews May Disenroll Vulnerable Dual Eligibles
Chart of the Day: Researchers Urge Easier Renewals and Better Support To Prevent Gaps in Care
New Study Reveals Death Rates During SSDI’s 24-Month Wait for Medicare
While They Wait for Medicare, People Approved for Social Security Disability Die at Higher Rates Compared to the General Public
How Parents Can Prepare for Major Medicaid Changes
Two Pediatricians Share Key Dates and Practical Next Steps
Medicare’s Hidden Fix for High Drug Costs
Medicare’s Payment Plan Can Ease Seniors’ Crushing Drug Costs but Medicare Buries it in the Fine Print
Patients Face New Barriers for GLP-1 Drugs Like Wegovy and Ozempic
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools